Host Cofactors and Pharmacologic Ligands Share an Essential Interface in HIV-1 Capsid That Is Lost upon Disassembly
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
The HIV-1 capsid is involved in all infectious steps from reverse transcription to integration site selection, and is the target of multiple host cell and pharmacologic ligands. However, structural studies have been limited to capsid monomers (CA), and the mechanistic basis for how these ligands influence infection is not well understood. Here we show that a multi-subunit interface formed exclusively within CA hexamers mediates binding to linear epitopes within cellular cofactors NUP153 and CPSF6, and is competed for by the antiretroviral compounds PF74 and BI-2. Each ligand is anchored via a shared phenylalanine-glycine (FG) motif to a pocket within the N-terminal domain of one monomer, and all but BI-2 also make essential interactions across the N-terminal domain: C-terminal domain (NTD:CTD) interface to a second monomer. Dissociation of hexamer into CA monomers prevents high affinity interaction with CPSF6 and PF74, and abolishes binding to NUP153. The second interface is conformationally dynamic, but binding of NUP153 or CPSF6 peptides is accommodated by only one conformation. NUP153 and CPSF6 have overlapping binding sites, but each makes unique CA interactions that, when mutated selectively, perturb cofactor dependency. These results reveal that multiple ligands share an overlapping interface in HIV-1 capsid that is lost upon viral disassembly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 CPSF6 and NUP153 interact with distinct sets of CA residues within the hexamer interface. A molecular surface representation of the CPSF6 and NUP153 binding site in hexameric capsid is shown in gray. The interface is formed between two neighbouring monomers and is shown in a similar orientation to Figure 3. The CPSF6 (A) and NUP153 (B) peptides in the different complexed structures are shown in yellow and pink respectively. The binding ‘footprint’ of each ligand is shown in red for CPSF6 and yellow for NUP153. The footprint was calculated using PISA [44] and is defined as residues containing atoms that become desolvated upon binding (i.e. are within 1.4 Å of the ligand).](https://figures.cochat.ai/paper-figures/327adc62c78b4401a48bf088e2d7894f/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-4.jpg)


![Figure 7 HIV-1 CA hexamer complexes with pharmacologic ligands BI-2 and PF74. Two monomers from hexameric structures complexed with BI-2 (A) and PF74 (B) are shown in a close-up view of the binding site, with one monomer in gray and a second monomer in teal. BI-2 is shown in orange and PF74 in green. Important CA interacting residues are shown as sticks and putative hydrogen bonds indicated by dashed lines. Ligplots [45] are shown for BI-2 (C) and PF74 (D) in which a ball-and-stick representation of the ligand is shown together with CA residues that contribute a hydrogen bond. Other interacting CA residues are indicated with a red-dashed semi-circle. Circled areas indicate interacting CA residues that are shared between both structures. (E) Superposition of the BI-2:hexamer complex (BI-2 in orange) with the previously solved BI-1:CA-NTD complex [28] (BI-1 in blue). The secondary structure of the superposed monomers from each structure is shown in gray, while capsid side-chains from only the hexamer complex are depicted. The adjacent monomer in the hexamer complex is shown in teal. (F) Superposition of the PF74:hexamer complex (PF74 in green) with the previously solved PF74:CA-NTD complex [27] (PF74 in slate). The capsids are colored as in (E).](https://figures.cochat.ai/paper-figures/7cf5249be85940bd90f08d2edaf59d69/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-7.jpg)

![Figure 9 Inhibition of HIV-1 infection by BI-2, PF74 and PF74 derivatives. (A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GFP-encoding HIV-1 vector. For each titration, infectivity is normalised to the level in the absence of inhibitor (100%). (B) Correlation between the IC90 values derived from (A) and the Kd values for purified hexameric capsid as calculated by ITC (Figure 8). The values are highly correlative with a Pearson correlation coefficient of 0.9928 and a P-value of 0.0007. (C) Titration of PF74 or BI-2 onto cells infected with VSV-G pseudotyped GFP-encoding HIV-1 vectors, normalized as in (A). (D) Data from (C) but with infectivity plotted against drug concentration divided by affinity to hexamer as calculated by ITC. (E) Titres of VSV-G pseudotyped GFP-encoding HIV-1 vectors 48 h post-infection and levels of reverse transcription (RT) 4 h post-infection under conditions of PF74 inhibition. For both measures, data are normalized to the values obtained in the absence of inhibitor. (F) Data from (E), except plotted against the calculated level of CA occupancy by PF74. The occupancy was calculated assuming that there are 1500 free sites per capsid and that number of free sites = 1500(1−([PF74]/Kd[PF74])) (G) Infectivity and reverse transcription in cells infected in the presence of PF74 (wash) or when removed after four hours (wash out). Reverse transcription was then measured after a further 4 h, while infectivity was determined 48 h post-infection. (H) Levels of reverse transcription 4 h post-infection of HeLa cells in the presence of PF74 and its derivatives at 20× IC9o drug concentrations.](https://figures.cochat.ai/paper-figures/fc100b1cf62b406592ce6fd8f22ac865/host-cofactors-and-pharmacologic-ligands-share-an-essential-interface-in-hiv-1-figure-9.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cleavage and polyadenylation specificity factor 6 (CPSF6), which is a component of the cellular pre-mRNA cleavage and polyadenylation machinery79, binds the same region of capsid as Nup153 (REF.78,80).”
From Structure and function of retroviral integrase (2022) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984 · cited 1×
“The footprint was calculated using PISA [44] and is defined as residues containing atoms that become desolvated upon binding (i.”
MethodLigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
Laskowski, R. A., & Swindells, M. B. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200227u · Cited by 6,471 · cited 1×
“Ligplots [45] are shown for BI-2 (C) and PF74 (D) in which a ball-and-stick representation of the ligand is shown together with CA residues that contribute a hydrogen bond.”
BackgroundIn Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Global Analysis of Host-Pathogen Interactions that Regulate Early-Stage HIV-1 Replication
König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Irelan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.032 · Cited by 960
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
Specific incorporation of cyclophilin A into HIV-1 virions
Franke, E. K., Yuan, H. E. H., & Luban, J. (1994) · Nature · doi:10.1038/372359a0 · Cited by 745
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 2×
“proteins TNPO3, NUP153, NUP358 [4,5,6], and LEDGF [7].”
X-Ray Structures of the Hexameric Building Block of the HIV Capsid
Pornillos, O., Ganser-Pornillos, B. K., Kelly, B. N., Hua, Y., Whitby, F. G., Stout, C. D., Sundquist, W. I., Hill, C. P., & Yeager, M. (2009) · Cell · doi:10.1016/j.cell.2009.04.063 · Cited by 523 · cited 4×
“One potential explanation for this is that all three structures were solved using monomeric CA NTD, whereas a fully assembled HIV-1 capsid is comprised exclusively of multimeric CA, predominately hexamers, containing both NTD-NTD and NTD-CTD interfaces [31].”
BackgroundInfluential
Cited by
HIV-1 assembly, release and maturation
Freed, E. O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3490 · Cited by 654
Pellegrini, L., Albecka, A., Mallery, D. L., Kellner, M. J., Paul, D., Carter, A. P., James, L. C., & Lancaster, M. A. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.001 · Cited by 552
Self-citationThe Structure of the Nuclear Pore Complex (An Update)
Lin, D. H., & Hoelz, A. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-011901 · Cited by 478
Clinical targeting of HIV capsid protein with a long-acting small molecule
Link, J. O., Rhee, M. S., Tse, W. C., Zheng, J., Somoza, J. R., Rowe, W., Begley, R., Chiu, A., Mulato, A., Hansen, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2443-1 · Cited by 425
HIV-1 capsid: the multifaceted key player in HIV-1 infection
Campbell, E. M., & Hope, T. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3503 · Cited by 430
The Immune Escape Mechanisms of Mycobacterium Tuberculosis
Zhai, W., Wu, F., Zhang, Y., Fu, Y., & Liu, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020340 · Cited by 392
“Th2 cells secrete IL-4, IL-5 and IL-10, which have negative effects on the immune response [61].”
BackgroundCone-shaped HIV-1 capsids are transported through intact nuclear pores
Zila, V., Margiotta, E., Turoňová, B., Müller, T. G., Zimmerli, C. E., Mattei, S., Allegretti, M., Börner, K., Rada, J., Müller, B., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.025 · Cited by 339
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion
Papa, G., Mallery, D. L., Albecka, A., Welch, L. G., Cattin-Ortolá, J., Luptak, J., Paul, D., McMahon, H. T., Goodfellow, I. G., Carter, A., et al. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009246 · Cited by 329
“Replication deficient VSV-G or SARS SARS-CoV-2 pseudotyped HIV-1 virions were produced in 293T wild-type (293T-wt) cells by transfection with pMDG2 or pCAGGS-S Δc19, pCRV GagPol and CSGW as described previously [50].”
MethodSelf-citationStructural basis of HIV-1 capsid recognition by PF74 and CPSF6
Bhattacharya, A., Alam, S. L., Fricke, T., Zadrozny, K., Sedzicki, J., Taylor, A. B., Demeler, B., Pornillos, O., Ganser-Pornillos, B. K., Diaz-Griffero, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419945112 · Cited by 266
“(30) also showing binding of small molecule drugs and host factors to”
BackgroundX-ray crystal structures of native HIV-1 capsid protein reveal conformational variability
Gres, A. T., Kirby, K. A., KewalRamani, V. N., Tanner, J. J., Pornillos, O., & Sarafianos, S. G. (2015) · Science · doi:10.1126/science.aaa5936 · Cited by 248
Structural and mechanistic bases for a potent HIV-1 capsid inhibitor
Bester, S. M., Wei, G., Zhao, H., Adu-Ampratwum, D., Iqbal, N., Courouble, V. V., Francis, A. C., Annamalai, A. S., Singh, P. K., Shkriabai, N., et al. (2020) · Science · doi:10.1126/science.abb4808 · Cited by 239
HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis
Jacques, D. A., McEwan, W. A., Hilditch, L., Price, A. J., Towers, G. J., & James, L. C. (2016) · Nature · doi:10.1038/nature19098 · Cited by 230
Self-citationUpdate and latest advances in antiretroviral therapy
Menéndez-Arias, L., & Delgado, R. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.10.004 · Cited by 223
Bejarano, D. A., Peng, K., Laketa, V., Börner, K., Jost, K. L., Lucic, B., Glass, B., Lusic, M., Müller, B., & Kräusslich, H.-G. (2019) · eLife · doi:10.7554/elife.41800 · Cited by 197
“Structural studies revealed that the compound preferentially binds to the assembled CA hexamer, where it targets a pocket that serves as binding site for CPSF6 and for the nucleoporin Nup153 (Price et al., 2014; Bhattacharya et al., 2014).”
BackgroundFrancis, A. C., & Melikyan, G. B. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.03.009 · Cited by 175
“…responsible for HIV-1 docking at the NE was explored using PF74; this compound binds to the same pocket, formed by the NTD-CTD interface of the CA hexamer, as the cellular factors, CPSF6 and Nup153 (Bhattacharya et al., 2014; Blair et al., 2010; Matreyek et al., 2013; Price et al., 2014).”
BackgroundInfluentialIP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis
Mallery, D. L., Márquez, C. L., McEwan, W. A., Dickson, C. F., Jacques, D. A., Anandapadamanaban, M., Bichel, K., Towers, G. J., Saiardi, A., Böcking, T., et al. (2018) · eLife · doi:10.7554/elife.35335 · Cited by 170
Self-citationRestriction of HIV-1 and other retroviruses by TRIM5
Ganser-Pornillos, B. K., & Pornillos, O. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0225-2 · Cited by 163
Francis, A. C., Marin, M., Singh, P. K., Achuthan, V., Prellberg, M. J., Palermino-Rowland, K., Lan, S., Tedbury, P. R., Sarafianos, S. G., Engelman, A. N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17256-8 · Cited by 159
Peng, K., Muranyi, W., Glass, B., Laketa, V., Yant, S. R., Tsai, L., Cihlar, T., Müller, B., & Kräusslich, H.-G. (2014) · eLife · doi:10.7554/elife.04114 · Cited by 158
“revealed that the CA hexamer of the mature lattice (and not monomeric CA) constitutes the optimal interface for Nup153 and CPSF6, which have overlapping binding sites on the capsid that are lost upon disassembly (Price et al., 2014).”
BackgroundYant, S. R., Mulato, A., Hansen, D., Tse, W. C., Niedziela-Majka, A., Zhang, J. R., Stepan, G. J., Jin, D., Wong, M. H., Perreira, J. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0560-x · Cited by 154
Chromatin organization at the nuclear pore favours HIV replication
Lelek, M., Casartelli, N., Pellin, D., Rizzi, E., Souque, P., Severgnini, M., Di Serio, C., Fricke, T., Diaz-Griffero, F., Zimmer, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7483 · Cited by 136
Reverse transcription mechanically initiates HIV-1 capsid disassembly
Rankovic, S., Varadarajan, J., Ramalho, R., Aiken, C., & Rousso, I. (2017) · Journal of Virology · doi:10.1128/jvi.00289-17 · Cited by 130
“The cellular proteins cyclophilin A and CPSF6 (6, 7) interact with the viral capsid and appear to influence infection by controlling uncoating (8, 9).”
BackgroundSelf-citationStructure and function of retroviral integrase
Maertens, G. N., Engelman, A. N., & Cherepanov, P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00586-9 · Cited by 124
Müller, T. G., Zila, V., Peters, K., Schifferdecker, S., Stanic, M., Lucic, B., Laketa, V., Lusic, M., Müller, B., & Kräusslich, H.-G. (2021) · eLife · doi:10.7554/elife.64776 · Cited by 123
Capsid-Dependent Host Factors in HIV-1 Infection
Yamashita, M., & Engelman, A. N. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.04.004 · Cited by 122
“(E) Primary interaction site between CPSF6313-327 (magenta) and the CA NTD (PDB code 4U0B) [69].”
BackgroundInfluentialTime-Resolved Imaging of Single HIV-1 Uncoating In Vitro and in Living Cells
Francis, A. C., Marin, M., Shi, J., Aiken, C., & Melikyan, G. B. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005709 · Cited by 118
Self-citationKIF5B and Nup358 Cooperatively Mediate the Nuclear Import of HIV-1 during Infection
Dharan, A., Talley, S., Tripathi, A., Mamede, J. I., Majetschak, M., Hope, T. J., & Campbell, E. M. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005700 · Cited by 116
“In the case of Nup153, the ability to support HIV-1 infection maps to the viral CA protein [21], and structural studies have found that the phenylalanine/glycine repeats (FG repeats) present on Nup153 are able to bind a conserved “pocket” on assembled CA[22,23,24,25].”
BackgroundInhibitors of the HIV-1 capsid, a target of opportunity
Carnes, S. K., Sheehan, J. H., & Aiken, C. (2018) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000472 · Cited by 113
“PF74 occupies a pocket at the NTD–CTD intersubunit interface, at which the host proteins CPSF6 and Nup153 also bind [32,33] (Fig.”
Self-citationSun, L., Huang, T., Dick, A., Meuser, M. E., Zalloum, W. A., Chen, C., Ding, X., Gao, P., Cocklin, S., Lee, K., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112085 · Cited by 113
Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis
Márquez, C. L., Lau, D., Walsh, J., Shah, V., McGuinness, C., Wong, A., Aggarwal, A., Parker, M. W., Jacques, D. A., Turville, S., et al. (2018) · eLife · doi:10.7554/elife.34772 · Cited by 111
“PF74 on the other hand binds in a pocket between CA subunits in a hexamer and stabilizes the hexameric lattice (Bhattacharya et al., 2014; Price et al., 2014).”
BackgroundInfluentialSelf-citationNup153 unlocks the nuclear pore complex for HIV-1 nuclear translocation in nondividing cells
Buffone, C., Martinez-Lopez, A., Fricke, T., Opp, S., Severgnini, M., Cifola, I., Petiti, L., Frabetti, S., Skorupka, K., Zadrozny, K. K., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00648-18 · Cited by 109
“We obtained two different crystal forms distinct from those reported by Price and colleagues (43).”
BackgroundMethodResultInfluentialHulme, A. E., Kelley, Z., Foley, D., & Hope, T. J. (2015) · Journal of Virology · doi:10.1128/jvi.00476-15 · Cited by 107
“Recently the high-affinity binding of PF74 to the hexameric form of CA has been used to support the model whereby HIV uncoats at the nuclear pore (31, 32).”
BackgroundMethodInfluentialPrimate TRIM5 proteins form hexagonal nets on HIV-1 capsids
Li, Y.-L., Chandrasekaran, V., Carter, S. D., Woodward, C. L., Christensen, D. E., Dryden, K. A., Pornillos, O., Yeager, M., Ganser-Pornillos, B. K., Jensen, G. J., et al. (2016) · eLife · doi:10.7554/elife.16269 · Cited by 105
“…of a series of proteins and drugs that have recently been described, including the proteins CPSF6 (Bhattacharya et al., 2014; Lee et al., 2010; Price et al., 2014), Nup153 (Bhattacharya et al., 2014; Di Nunzio et al., 2013; Matreyek et al., 2013; Price et al., 2014), and Nup358 (Bichel et…”
BackgroundDiscovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication
Maeda, K., Das, D., Kobayakawa, T., Tamamura, H., & Takeuchi, H. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190712204603 · Cited by 126
Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle
Novikova, M., Zhang, Y., Freed, E. O., & Peng, K. (2019) · Virologica Sinica · doi:10.1007/s12250-019-00095-3 · Cited by 116
HIV-1 Maturation: Lessons Learned from Inhibitors
Kleinpeter, A. B., & Freed, E. O. (2020) · Viruses · doi:10.3390/v12090940 · Cited by 119
“PF74 was shown to bind to an intermolecular interface between the CA-NTD of one subunit and the CA-CTD of an adjacent subunit within the mature CA hexamer [32,47,48].”
BackgroundInfluentialNuclear Capsid Uncoating and Reverse Transcription of HIV-1
Müller, T. G., Zila, V., Müller, B., & Kräusslich, H.-G. (2022) · Annual Review of Virology · doi:10.1146/annurev-virology-020922-110929 · Cited by 94
Passage of the HIV capsid cracks the nuclear pore
Kreysing, J. P., Heidari, M., Žíla, V., Cruz-León, S., Obarska-Kosińska, A., Laketa, V., Rohleder, L., Welsch, S., Köfinger, J., Turoňová, B., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.008 · Cited by 102
“MDMs were incubated with NNHIV for 48 h, stained for HIV-1 CA and FG-Nups, and super-resolved images acquired in sequential optical sections to cover the entire nuclear volume of individual cells.”
InfluentialAll-Atom Molecular Dynamics of Virus Capsids as Drug Targets
Perilla, J. R., Hadden‐Perilla, J. A., Goh, B. C., Mayne, C. G., & Schulten, K. J. (2016) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.6b00517 · Cited by 101
Cellular and molecular mechanisms of HIV-1 integration targeting
Engelman, A., & Singh, P. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2772-5 · Cited by 113
“The binding sites for NUP153 and CPSF6 on the capsid overlap [130, 164, 165], but in each case only relatively short peptides of the host factors have been crystallized with capsid (Fig.”
BackgroundMallery, D. L., Faysal, K. M. R., Kleinpeter, A. B., Wilson, M., Vaysburd, M., Fletcher, A. J., Novikova, M., Böcking, T., Freed, E. O., Saiardi, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.050 · Cited by 89
“Importantly, Nup153 can only bind intact mature hexamers, meaning that its binding is sensitive to capsid oligomerization (Price et al., 2014).”
BackgroundSelf-citationRemodeling of the Core Leads HIV-1 Preintegration Complex into the Nucleus of Human Lymphocytes
Blanco-Rodriguez, G., Gazi, A. D., Monel, B., Frabetti, S., Scoca, V., Mueller, F., Schwartz, O., Krijnse‐Locker, J., Charneau, P., & Nunzio, F. D. (2020) · Journal of Virology · doi:10.1128/jvi.00135-20 · Cited by 103
“PF74 binds at the interface between the N-terminal domain (NTD) and the C-terminal domain (CTD) (19, 42) of CA, thus inhibiting HIV-1 infection by blocking nuclear entry in a reportedly bimodal dose-dependent mechanism (19, 42–44).”
BackgroundRoles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74
Saito, A., Ferhadian, D., Sowd, G. A., Serrao, E., Shi, J., Halambage, U. D., Teng, S., Soto, J., Siddiqui, M. A., Engelman, A. N., et al. (2016) · Journal of Virology · doi:10.1128/jvi.03116-15 · Cited by 88
Self-citationStructure, Function, and Interactions of the HIV-1 Capsid Protein
Rossi, E., Meuser, M. E., Cunanan, C. J., & Cocklin, S. (2021) · Life · doi:10.3390/life11020100 · Cited by 141
HIV-1 capsids enter the FG phase of nuclear pores like a transport receptor
Fu, L., Weiskopf, E. N., Akkermans, O., Swanson, N. A., Cheng, S., Schwartz, T., & Görlich, D. (2024) · Nature · doi:10.1038/s41586-023-06966-w · Cited by 94
The HIV capsid mimics karyopherin engagement of FG-nucleoporins
Dickson, C. F., Hertel, S., Tuckwell, A., Li, N., Ruan, J., Al-Izzi, S. C., Ariotti, N., Sierecki, E., Gambin, Y., Morris, R. G., et al. (2024) · Nature · doi:10.1038/s41586-023-06969-7 · Cited by 90
“CPSF6 313–327 peptide preferentially binds to CA hexamer ( K d = 50 µM) over unassembled CA ( K d approximately 700 µM) 16 .”
BackgroundSelf-citationHIV-1 Capsid Inhibitors as Antiretroviral Agents
Thenin-Houssier, S., & Valente, S. T. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224103555 · Cited by 86
“However, unlike PF74, BI-2 does not make interaction across adjacent monomers in the context of the hexameric capsid [61].”
BackgroundResultInfluentialPF74 Reinforces the HIV-1 Capsid To Impair Reverse Transcription-Induced Uncoating
Rankovic, S., Ramalho, R., Aiken, C., & Rousso, I. (2018) · Journal of Virology · doi:10.1128/jvi.00845-18 · Cited by 80
“PF74’s antiviral activity is also modulated by capsid-binding host factors, including cyclophilin A and NUP153.”
BackgroundInfluentialSelf-citationSec24C is an HIV-1 host dependency factor crucial for virus replication
Rebensburg, S. V., Wei, G., Larue, R. C., Lindenberger, J. J., Francis, A. C., Annamalai, A. S., Morrison, J. H., Shkriabai, N., Huang, S., KewalRamani, V. N., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00868-1 · Cited by 83
Demeulemeester, J., De Rijck, J., Gijsbers, R., & Debyser, Z. (2015) · BioEssays · doi:10.1002/bies.201500051 · Cited by 71
“Moreover, several HIV capsid mutants that perturb binding to Nup358, Nup153 or cyclophilin A and/or alter capsid stability also affect integration site selection [28, 39, 40].”
BackgroundIP6 Regulation of HIV Capsid Assembly, Stability, and Uncoating
Dick, R. A., Mallery, D. L., Vogt, V. M., & James, L. C. (2018) · Viruses · doi:10.3390/v10110640 · Cited by 71
“Exactly when (and where) uncoating occurs is controversial, but the capsid probably remains largely intact at least until the virus reaches the nuclear pore since interaction with the nuclear pore protein Nup153 requires mature hexamers [36].”
BackgroundSelf-citationFEZ1 Is Recruited to a Conserved Cofactor Site on Capsid to Promote HIV-1 Trafficking
Huang, P.-T., Summers, B. J., Xu, C., Perilla, J. R., Malikov, V., Naghavi, M. H., & Xiong, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.079 · Cited by 70
“This binding affinity is at least an order of magnitude higher than previously analyzed capsid-binding proteins such as CypA, TRIM5α, TRIMCyp, CPSF6, and Nup153 (Bhattacharya et al., 2014; Biris et al., 2012; Price et al., 2014; Yoo et al., 1997; Zhou et al., 2015), making FEZ1 the strongest CA hexamer binder known to…”
ResultHIV-1 capsid is involved in post-nuclear entry steps
Chen, N.-Y., Zhou, L., Gane, P. J., Opp, S., Ball, N. J., Nicastro, G., Zufferey, M., Buffone, C., Luban, J., Selwood, D., et al. (2016) · Retrovirology · doi:10.1186/s12977-016-0262-0 · Cited by 68
“It is presently unclear how C-A1 might enhance capsid binding to CPSF6 given that the C-A1 binding cleft is predicted to partly overlap with that one of PF-74 and BI-1.”
InfluentialNi, T., Gerard, S., Zhao, G., Dent, K., Ning, J., Zhou, J., Shi, J., Anderson-Daniels, J., Li, W., Jang, S., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0467-8 · Cited by 68
Self-citationA stable immature lattice packages IP 6 for HIV capsid maturation
Mallery, D. L., Kleinpeter, A. B., Renner, N., Faysal, K. M. R., Novikova, M., Kiss, L., Wilson, M., Ahsan, B., Ke, Z., Briggs, J. A. G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe4716 · Cited by 69
Self-citationRotten to the core: antivirals targeting the HIV-1 capsid core
McFadden, W. M., Snyder, A. A., Kirby, K. A., Tedbury, P. R., Raj, M., Wang, Z., & Sarafianos, S. G. (2021) · Retrovirology · doi:10.1186/s12977-021-00583-z · Cited by 73
“Structural studies of PF74 with CANTD [137], cross-linked CA hexamers [139], or native CA [105] Fig.”
BackgroundWu, G., Zalloum, W. A., Meuser, M. E., Jing, L., Kang, D., Chen, C., Tian, Y., Zhang, F., Cocklin, S., Lee, K., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.029 · Cited by 66
“These values are consistent with the previous affinity studies reported in the literature [13, 24, 26] and demonstrate that PF-74 has a preference for binding to the hexameric form of the CA protein.”
BackgroundResultRasheedi, S., Shun, M.-C., Serrao, E., Sowd, G. A., Qian, J., Hao, C., Dasgupta, T., Engelman, A. N., & Skowronski, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721647 · Cited by 65
“Of note, whereas the possibility that the A14C/E45C cross-link modifies the interaction with full-length CPSF6 and/or CFIm complex cannot be excluded, the published CA structures do not raise a concern that this modification could interfere with CPSF6 binding via the previously defined canonical CA-binding peptide (7,…”
BackgroundLi, W., Singh, P. K., Sowd, G. A., Bedwell, G. J., Jang, S., Achuthan, V., Oleru, A. V., Wong, D., Fadel, H. J., Lee, K., et al. (2020) · mBio · doi:10.1128/mbio.02254-20 · Cited by 64
“Because CPSF6 276–290 and CPSF6 276–290/F284A peptides bound EIAV capsid NTD protein at similar affinities, we cannot exclude an interaction between EIAV capsid and CPSF6, although this would have to fundamentally differ from the known interaction with HIV-1 capsid (36, 37, 45, 49).”
Saito, A., Henning, M. S., Serrao, E., Dubose, B. N., Teng, S., Huang, J., Li, X., Saito, N., Roy, S. P., Siddiqui, M. A., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00019-16 · Cited by 63
“Additionally, the Cterminal domain of CA also provides binding determinants for CPSF6 (39, 40).”
BackgroundZhou, J., Price, A. J., Halambage, U. D., James, L. C., & Aiken, C. (2015) · Journal of Virology · doi:10.1128/jvi.00340-15 · Cited by 64
“More recently, we and others reported that at moderate concentrations, PF74 antiviral action was correlated with reduction in accumulation of 2-long terminal repeat (2-LTR) circles (30, 45).”
BackgroundMethodInfluentialSelf-citationZhong, Z., Ning, J., Boggs, E. A., Jang, S., Wallace, C. T., Telmer, C. A., Bruchez, M. P., Ahn, J., Engelman, A., Zhang, P., et al. (2021) · mBio · doi:10.1128/mbio.03142-20 · Cited by 64
“Disruption of CPSF6 binding to HIV-1 capsid is mediated by alteration of CPSF6 at amino acid F321 in the central proline-rich domain (37) or by mutations in CA, including residues 57, 70, 74, 77, and 105 (21, 32, 38, 39).”
BackgroundJiang, X., Wu, G., Zalloum, W. A., Meuser, M. E., Dick, A., Sun, L., Chen, C., Kang, D., Jing, L., Jia, R., et al. (2019) · RSC Advances · doi:10.1039/c9ra05869a · Cited by 61
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
Singh, K. D., Gallazzi, F., Hill, K. J., Burke, D. H., Lange, M. J., Quinn, T. P., Neogi, U., & Sönnerborg, A. B. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01227 · Cited by 60
“If administered efficiently, cART significantly reduces morbidity and mortality of HIV-infected individuals, both in resource-rich and in low- and middle-income countries (Quinn, 2008; Sabin, 2013; May et al., 2014; Harries et al., 2016; Teeraananchai et al., 2017).”
HIV capsid and integration targeting
Engelman, A. N. (2021) · Viruses · doi:10.3390/v13010125 · Cited by 57
“residues 313–327 (green; PDB code 4U0B) [31].”
BackgroundInfluentialTwo structural switches in HIV-1 capsid regulate capsid curvature and host factor binding
Stacey, J. C. V., Tan, A., Lu, J. M., James, L. C., Dick, R. A., & Briggs, J. A. G. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220557120 · Cited by 58
“For structures of hexamers adjacent to pentamers, particle positions were derived in one of two ways; either through 3D-classification of previously derived hexamer positions, as was the case for the uncomplexed and Nup153 (1407-1423) datasets, or through symmetry expanding pentamer positions and shifting of the parti…”
InfluentialSelf-citationStructural and Mechanistic Bases of Viral Resistance to HIV-1 Capsid Inhibitor Lenacapavir
Bester, S. M., Adu‐Ampratwum, D., Annamalai, A. S., Wei, G., Briganti, L., Murphy, B. C., Haney, R., Fuchs, J. R., & Kvaratskhelia, M. (2022) · mBio · doi:10.1128/mbio.01804-22 · Cited by 61
“In contrast, with these cofactors, the N74D substitution does not affect NUP153 binding to HIV-1 CA (10), as this CA residue is at least 7.”
BackgroundA molecular switch modulates assembly and host factor binding of the HIV-1 capsid
Schirra, R. T., dos Santos, N. F. B., Zadrozny, K. K., Kucharska, I., Ganser‐Pornillos, B. K., & Pornillos, O. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00913-5 · Cited by 71
Highland, C. M., Tan, A., Ricana, C. L., Briggs, J. A. G., & Dick, R. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220545120 · Cited by 59
Balasubramaniam, M., Pandhare, J., & Dash, C. (2019) · JoLS Journal of Life Sciences · doi:10.36069/jols/20190603 · Cited by 85
HIV-1 is dependent on its immature lattice to recruit IP6 for mature capsid assembly
Renner, N., Kleinpeter, A., Mallery, D. L., Albecka, A., Rifat Faysal, K. M., Böcking, T., Saiardi, A., Freed, E. O., & James, L. C. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00887-4 · Cited by 51
Self-citationAnalysis of HIV-1 Gag Protein Interactions via Biotin Ligase Tagging
Ritchie, C., Cylinder, I., Platt, E. J., & Barklis, E. (2015) · Journal of Virology · doi:10.1128/jvi.03584-14 · Cited by 52
“More recently, PIC-associated CA has been shown to bind to karyopherin substrate 81 CPSF6 and the nucleoporin proteins Nup153 and Nup358 to facilitate the nuclear localization of 82 PICs (39-42).”
BackgroundInfluentialFrancis, A. C., Marin, M., Prellberg, M. J., Palermino-Rowland, K., & Melikyan, G. B. (2020) · Viruses · doi:10.3390/v12111234 · Cited by 53
Zhuang, S., & Torbett, B. E. (2021) · Viruses · doi:10.3390/v13030417 · Cited by 55
“GS-6207 (Lenacapavir) stabilizes capsid and competes with the capsid binding host factors CPSF6 and Nup153, thereby disrupting nuclear import [29].”
BackgroundInfluentialPrion-like low complexity regions enable avid virus-host interactions during HIV-1 infection
Wei, G., Iqbal, N., Courouble, V. V., Francis, A. C., Singh, P. K., Hudait, A., Annamalai, A. S., Bester, S. M., Huang, S., Shkriabai, N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33662-6 · Cited by 59
HIV Capsid Assembly, Mechanism, and Structure
Chen, B. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00159 · Cited by 64
A lysine ring in HIV capsid pores coordinates IP6 to drive mature capsid assembly
Renner, N., Mallery, D. L., Faysal, K. M. R., Peng, W., Jacques, D. A., Böcking, T., & James, L. C. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009164 · Cited by 53
“Replication deficient VSV-G pseudotyped HIV-1 virions were produced in HEK293T cells using the lentiviral packaging plasmid pMDG2, which encodes VSV-G envelope (Addgene plasmid # 12259) pCRV GagPol [28] and CSGW [29] as described previously [30].”
MethodSelf-citationModeling HIV-1 nuclear entry with nucleoporin-gated DNA-origami channels
Shen, Q., Feng, Q., Wu, C., Xiong, Q., Tian, T., Yuan, S., Shi, J., Bedwell, G. J., Yang, R., Aiken, C., et al. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-00925-9 · Cited by 50
Self-citationSUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV
Donahue, D. A., Amraoui, S., Nunzio, F. D., Kieffer, C., Porrot, F., Opp, S., Diaz‐Griffero, F., Casartelli, N., & Schwartz, O. (2016) · Journal of Virology · doi:10.1128/jvi.03202-15 · Cited by 56
Shen, Q., Wu, C., Freniere, C., Tripler, T. N., & Xiong, Y. (2021) · Viruses · doi:10.3390/v13112242 · Cited by 62
“Structural studies have shown that this NUP153 FG-motif is engaged at the NTD–CTD interface between two CA subunits of the hexamer, albeit with a relatively weak binding affinity (Kd) of ~50 μM [60,63].”
BackgroundUnderstanding Virus Structure and Dynamics through Molecular Simulations
Lynch, D. L., Pavlova, A., Fan, Z., & Gumbart, J. C. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00116 · Cited by 47
Cellular and viral determinants of retroviral nuclear entry
Hamid, F. B., Kim, J., & Shin, C.-G. (2016) · Canadian Journal of Microbiology · doi:10.1139/cjm-2015-0350 · Cited by 48
Pak, A. J., Grime, J. M. A., Yu, A., & Voth, G. A. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b01413 · Cited by 51
HIV-1 requires capsid remodelling at the nuclear pore for nuclear entry and integration
Guedán, A., Donaldson, C. D., Caroe, E. R., Cosnefroy, O., Taylor, I. A., & Bishop, K. N. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009484 · Cited by 51
“At each time point, cells were fixed, and proximity ligation assays (PLA) were performed with specific antibody combinations: anti-HIV-1 CA and anti-Nup358 (Fig 7A-C), and anti-HIV-1 CA and anti-Nup153 (Fig 7D-F).”
BackgroundInfluentialMachida, S., Depierre, D., Chen, H., Thenin-Houssier, S., Petitjean, G., Doyen, C. M., Takaku, M., Cuvier, O., & Benkirane, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913754117 · Cited by 46
Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure
Faysal, K. M. R., Walsh, J. C., Renner, N., Márquez, C. L., Shah, V. B., Tuckwell, A., Christie, M. P., Parker, M. W., Turville, S. G., James, L. C., et al. (2024) · eLife · doi:10.7554/elife.83605 · Cited by 49
Self-citationMachara, A., Lux, V., Kožíšek, M., Šašková, K. G., Štěpánek, O., Kotora, M., Parkan, K., Pávová, M., Glass, B., Sehr, P. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01089 · Cited by 46
SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses
Carnell, G., Ciazynska, K. A., Wells, D. A., Xiong, X., Aguinam, E. T., McLaughlin, S. H., Mallery, D. L., Ebrahimi, S., Ceron‐Gutierrez, L., Asbach, B., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00203-21 · Cited by 48
Self-citationRecognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA
Yoh, S. M., Mamede, J. I., Lau, D., Ahn, N., Sánchez-Aparicio, M. T., Temple, J. E., Tuckwell, A., Fuchs, N. V., Cianci, G. C., Riva, L., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.06.010 · Cited by 47
HIV-induced membraneless organelles orchestrate post-nuclear entry steps
Scoca, V., Morin, R., Collard, M., Tinévez, J.-Y., & Nunzio, F. D. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac060 · Cited by 53
Misdelivery at the Nuclear Pore Complex—Stopping a Virus Dead in Its Tracks
Flatt, J. W., & Greber, U. F. (2015) · Cells · doi:10.3390/cells4030277 · Cited by 48
“model, MxB acts as an HIV-1 capsid pattern sensor that associates with incoming viral capsids as an extended antiparallel dimer [125–128].”
BackgroundPF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex
Balasubramaniam, M., Zhou, J., Addai, A. B., Martinez, P., Pandhare, J., Aiken, C., & Dash, C. (2018) · Journal of Virology · doi:10.1128/jvi.01741-18 · Cited by 43
“Given that PF74 and CPSF6 share the same binding pocket in the capsid (56, 89), competition between PF74 and CPSF6 to bind the viral replication complex-associated CA in the nucleus would disrupt viral DNA integration.”
BackgroundSelf-citationA Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing
Siddiqui, M. A., Saito, A., Halambage, U. D., Ferhadian, D., Fischer, D. K., Francis, A. C., Melikyan, G. B., Ambrose, Z., Aiken, C., & Yamashita, M. (2019) · Journal of Virology · doi:10.1128/jvi.00706-19 · Cited by 45
Self-citationLabeling of virus components for advanced, quantitative imaging analyses
Sakin, V., Paci, G., Lemke, E. A., & Müller, B. (2016) · FEBS Letters · doi:10.1002/1873-3468.12131 · Cited by 48
Capsid-Labelled HIV To Investigate the Role of Capsid during Nuclear Import and Integration
Zurnic, I., Dirix, L., Lemmens, V., Borrenberghs, D., Wit, F. D., Vernaillen, F., Rocha, S., Christ, F., Hendrix, J., Hofkens, J., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01024-19 · Cited by 49
“Whether this role is restricted to docking of PICs on the cytoplasmic side of the nucleopore (e.g., through NUP358), involves capsid uncoating when stalled in the nuclear basket (e.g., through NUP153), or is mediated by a direct interaction between capsid and nuclear import factors is not known.”
BackgroundAn insight on medicinal aspects of novel HIV-1 capsid protein inhibitors
Sun, L., Zhang, X., Xu, S., Huang, T., Song, S. L., Cherukupalli, S., Zhan, P., & Liu, X. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113380 · Cited by 44
The capsid lattice engages a bipartite NUP153 motif to mediate nuclear entry of HIV-1 cores
Shen, Q., Kumari, S., Xu, C., Jang, S., Shi, J., Burdick, R. C., Levintov, L., Xiong, Q., Wu, C., Devarkar, S. C., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202815120 · Cited by 48
“…CA residues that are located in different regions of the capsid, including the tri-hexamer interface (E212A, E213A, E212A/E213A, E75A), the di-hexamer interface (E180A/E187A), the FG-pocket (N74D, Q67A, N57D), the CypA-binding loop (P90A, G89V), and the hexamer central pore (R18D) (21, 27, 36–38).”
InfluentialSelf-citationFactors that mold the nuclear landscape of HIV-1 integration
Bedwell, G. J., & Engelman, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1207 · Cited by 44
“Eventually, the core docks on the nuclear side of the NPC at the nuclear basket via the CA-Nup153 interaction (54,55,67).”
BackgroundThe MORPHEUS II protein crystallization screen
Gorrec, F. (2015) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x1500967x · Cited by 40
“…complex (‘E2H’, 115 kDa, 7 mg ml 1; Teo et al., 2004), bar domain (‘Bar’, 6 mg ml 1, 29 kDa; Peter et al., 2004), HIV capsid (‘HIV’, 25 kDa, 32 mg ml 1; Price et al., 2014), coiled-coil domain of the cytosolic nucleic acid sensor LRRFIP1 (‘CCD’, 12 kDa, 9 mg ml 1; Nguyen & Modis, 2013),…”
BackgroundA snapshot of HIV-1 capsid–host interactions
Temple, J. E., Tripler, T. N., Shen, Q., & Xiong, Y. (2020) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2020.10.002 · Cited by 37
Metadata
- Authors
- Price, A. J., Jacques, D. A., McEwan, W. A., Fletcher, A. J., Essig, S., Chin, J. W., Halambage, U. D., Aiken, C., & James, L. C.
- Affiliations
- MRC Laboratory of Molecular Biology (GB)
- Vanderbilt University (US)
- Corresponding author
- James, Leo C.
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-30
- Volume
- 10
- Issue
- 10
- Pages
- e1004459
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4214760
- OpenAlex
- W2170915201
- Cited by
- 284
- References
- 45
- Citations by year
- 2026: 16 · 2025: 27 · 2024: 23 · 2023: 24 · 2022: 21 · 2021: 41 · 2020: 31 · 2019: 28 · 2018: 24 · 2017: 8 · 2016: 19 · 2015: 20 · 2014: 2
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- UTS ePRESS (University of Technology Sydney) (submittedVersion)
- Funders
- National Institutes of Health
- Medical Research Council (U105181010)
- National Health and Medical Research Council (1036521)
- National Institute of Allergy and Infectious Diseases (R01AI089401)
- FP7 Ideas: European Research Council (281627)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 capsid, host cofactors, Nup153, CPSF6, capsid disassembly, conformational dynamics, antiretroviral drugs
- MeSH terms
- Binding Sites, Capsid, Humans, Indoles, Ligands, Models, Molecular, Models, Structural, Mutation, Phenylalanine, Polycyclic Compounds, Protein Binding, Virion, HIV-1, HIV Infections, Protein Structure, Tertiary, Anti-HIV Agents, Nuclear Pore Complex Proteins, Capsid Proteins, mRNA Cleavage and Polyadenylation Factors, Reverse Transcription, Polymerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.